Rare Earth Elements in National Defense, and More from CRS
New and updated reports from the Congressional Research Service obtained by Secrecy News include the following.
Rare Earth Elements in National Defense: Background, Oversight Issues, and Options for Congress, September 17, 2013
Chemical Weapons: A Summary Report of Characteristics and Effects, September 13, 2013
North Korea: U.S. Relations, Nuclear Diplomacy, and Internal Situation, September 13, 2013
Federal Climate Change Funding from FY2008 to FY2014, September 13, 2013
Climate Change Legislation in the 113th Congress, September 16, 2013
Federal Permitting and Oversight of Export of Fossil Fuels, September 17, 2013
Expiration and Extension of the 2008 Farm Bill, September 16, 2013
Guam: U.S. Defense Deployments, September 12, 2013
Russian Political, Economic, and Security Issues and U.S. Interests, September 13, 2013
The Supplemental Nutrition Assistance Program: Categorical Eligibility, September 17, 2013
Ticket to Work and Self-Sufficiency Program: Overview and Current Issues, September 13, 2013
Rebuilding Household Wealth: Implications for Economic Recovery, September 13, 2013
Consumers and Food Price Inflation, September 13, 2013
Synthetic Drugs: Overview and Issues for Congress, September 16, 2013
Confirmation that the construction of the security perimeter and associated security infrastructure at RAF Lakenheath are still ongoing once again raises questions about whether U.S. nuclear weapons have already been deployed to the base.
Alaskans are sensibly pulling back from the vogue for bans and returning to a western tradition that has worked for more than half a century – one that welcomes innovation but also oversees it closely.
The strength of our nation’s data policy isn’t just in the rules we write, but in how effectively we translate those rules into a system that prioritizes the public good. Join us in this movement to design and build more resilient national data policies.
The human cost is measured in deaths. The financial cost is measured in the $52 billion taxpayers pay annually end stage renal disease – double NASA’s budget.